Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Gemcitabine Plus Carboplatin in Patients With Pretreated Metastatic Breast Cancer

NCT00450762 is registered in ClinicalTrials.gov with Ludwig-Maximilians - University of Munich as lead sponsor.

NCT NCT00450762
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00450762 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Gemcitabine Plus Carboplatin in Patients With Pretreated Metastatic Breast Cancer
Lead sponsor
Ludwig-Maximilians - University of Munich
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2004
Completion date
October 31, 2006
Enrollment
Not reported
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer